Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at one noteworthy recent insider buy.
On Wednesday, Director Gordon M. Binder purchased $667,500 worth of Humacyte, purchasing 100,000 shares at a cost of $6.67 a piece. This buy marks the first one filed by Binder in the past year. Humacyte is trading up about 4% on the day Thursday.
VIDEO: Thursday 5/16 Insider Buying Report: HUMA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
